{'fraction_non_alphanumeric': 0.028391167192429023, 'fraction_numerical': 0.008412197686645636, 'mean_word_length': 5.704225352112676, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Dysesthetic ("essential") vulvodynia. Treatment with amitriptyline.

Twenty patients with chronic vulvar burning (vulvodynia) who had relief of symptoms only after treatment with low-dose amitriptyline were studied retrospectively. These patients had several factors in common, which suggested a possible neurologic component to their symptoms. The dosage of amitriptyline (initiated at 10 mg, gradually increased to 40-60 mg daily) was not sufficient to treat depression, but was in the range effective for other cutaneous dysesthesias. This study defines dysesthetic ("essential") vulvodynia, and describes a typical profile and symptom pattern for patients most likely to respond to treatment with amitriptyline (an average age of 66 with vulvodynia for three years). Dysesthetic vulvodynia appears to be a subset different from vulvar vestibulitis and other types of vulvodynia that are less responsive to treatment with tricyclic antidepressants.